Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Wuxi Medical lnstrument Factory Co., Ltd.
WARNING LETTER
•Wuxi Medical lnstrument Factory Co., Ltd.•March 10, 2017

Wuxi Medical lnstrument Factory Co., Ltd. – FDA Warning Letter, Mar 10, 2017

Record Details

The FDA issued a Warning Letter to Wuxi Medical Instrument Factory following an inspection from March 6-10, 2017, identifying significant violations of current Good Manufacturing Practice (CGMP) regulations for finished pharmaceuticals, rendering their drug products adulterated. The firm's March 31, 2017, response was deemed insufficient.

Key violations include: 1. **Failure to establish written procedures for production and process controls (21 CFR 211.100(a))**: The firm failed to adequately validate the manufacturing process for their sterile (b)(4), lacking process qualification batch records and sufficient data. Commercial batch records also omitted critical process parameters. 2. **Failure to establish adequate laboratory controls (21 CFR 211.160(b))**: The firm did not perform growth promotion testing on each batch of microbiological growth media used for testing and lacked a written procedure for media preparation. 3. **Failure to clean, maintain, and sanitize equipment (21 CFR 211.67(a))**: Clean (b)(4) tubing was stored in an open container with exposed ends, risking contamination of terminally sterilized drug products, and procedures for maintaining, cleaning, and sanitizing this tubing were absent. 4. **Failure to maintain adequate written records of major equipment maintenance (21 CFR 211.182)**: Records for (

Company
Wuxi Medical lnstrument Factory Co., Ltd.
Inspection date
March 10, 2017
Product type
Drugs
Office
Center for Drug Evaluation and Research
Person
  • Thomas J. Cosgrove
View Company Profile

ID · 99d7f628-0a38-429b-b7d3-4d6b193f71a0

Violation Codes10
21 U.S.C. 351(a)(2)(B)21 CFR 21021 CFR 211FD&C Act 501(a)(2)(B)21 CFR 211.100(a)21 CFR 211.160(b)21 CFR 211.67(a)21 CFR 211.182FD&C Act 801(a)(3)21 U.S.C. 381(a)(3)

Full citation text and observation details available on the Dashboard.

Other documents for Wuxi Medical lnstrument Factory Co., Ltd.
  • WARNING_LETTER - 2024-11-15November 15, 2024
  • 483 - 2024-11-15November 15, 2024

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Wuxi Medical lnstrument Factory Co., Ltd.
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.